Page 79 - 75_03
P. 79
VOL. 75 (3), 419-466, 2009 DIFERENCIACIÓN SEXUAL: EL FACTOR DE JOST
55. Kretzschmar, M. & Massagué, J. (1998) SMADS: mediators and regulators of
TGF-ß signalling. Curr. Opin. Genet. Dev. 8: 691-96.
56. Chen X., Rubock, M. J. et al. (1996) A transcriptional partner for SMAD
proteins in TGF-ß signalling. Nature. 383: 691-96.
57. Teixeira, J., He, W. W., Shah, P. C. et al. (1996) Developmental expression of
a candidate Müllerian inhibitng substance type II receptor. Endocrinol. 137:
160-165.
58. De Santa Barbara, P., Moniot, B. et al. (1998) Steroidogenic factor-1 regulates
transcription of the human anti-Mullerian hormona receptor. J. Biol. Chem.
273: 29654-550.
59. Parr, B. A. & McMahon, A. P. (1998) Sexually dimorphic development of the
mammalian reproductive tract requires Wnt-7a. Nature. 395: 707-710.
60. Visser, J. A., Olaso, R., Verhoef-Post, M. et al. (2001) The serine/threonine
transmenbrane receptor ALK2 mediates Müllerian inhibiting substance signa-
lling. Mol. Endocrinol. 15: 936-45.
61. Tsuji, M., Shima, H. et al. (1992) Effect of human recombinant Müllerian
inhibiting substance on isolated epithelial and mesenchymal cells during Mu-
llerian ducts regression in the rat. Endocrinol. 1331: 1481-88.
62. Chen, M. J., Yang, W. S. et al. (2008) The relationship between anti-Müllerian
hormone, androgen and insulin resistance on the number of antral follicles in
women with polycystic ovary syndrome. Hum. Reprod. 23(4): 962-957.
63. Lie Fong, S., Lugtembourg, P. J. et al. (2008) Anti-Müllerian hormone as a
marker of ovarian function in women after chemotherapy and radiotherapy
for haematological malignancies. Hum. Reprod. 23(3): 674-678.
64. Ueno, S., Manganaro, T. F. et al. (1988) Human recombinant mullerian inhi-
biting substance inhibition of rat oocyte meiosis is reverted by epidermal
growth factor in vitro. Endocrinol. 123: 1652-59.
65. Torday, J. S., Nielsen, H. C. et al. (1985) Sex differences in fetal lung madu-
ration. Am. Rev. Respir. Dis. 123: 205-8.
66. Lee, M. M., Seah, C. C., Masiakos, P. T. et al. (1999) Müllerian inhibiting
substance type II receptor expression and function in perifies rat Leydig cells.
Endocrinol. 140: 2619-27.
67. Behringer, R. R., Finegold, M. J. et al. (1994) Mullerian inhibiting substance
function during mammalian sexual development. Cell. 79: 415-25.
68. Mishina, Y., Rey, R. et al. (1996) Genetic analysis of the Müllerian inhibiting
substance signal transduction pathway in mammalian sexual differentiation.
Genes Dev. 10: 2577-87.
69. Hamilton, T. H. & Teng, C. S. (1965) Sexual stabilitation of Müllerian ducts
in the chick embryon, en De Haan, R. I., Ursprung, H. eds., Organogenesis
New York Holt. Rinehart and Wisnston, 681-700.
70. Scuffy, R. E. (1970) Recent progress in ovarian cancer. Hum. Pathol. 1: 73-98.
71. Donahoe, P. K., Swan, D. A., Hayashi, A. et al. (1979) Müllerian ducts regre-
sion in the embryo correlated with cytotoxic activity against human ovarian
cancer. Science. 205: 913-915.
72. Fuller, A. F. J. Guy, S., Donahoe, P. K. et al. (1982) Müllerian inhibiting
substance inhibits colony growth of a human ovarian carcinoma line. J. Clin.
Endocrinol. Metab. 54: 1051-55.
465
